ZitSticka Investor BFG Touts Startup’s Grownup Following, ‘And They Have Done It With One Product’
Executive Summary
Australia-born ZitSticka, marketer of the Killa patch with microdart technology to address “early-stage” zits, will use $5m in Series A financing to support upcoming product launch activity, it says.
You may also be interested in...
Innovating Outside OTC Monograph Lines: Trending Acne Patches, Hand And Foot Antiperspirants
Industry and the FDA agree that the OTC drug monograph system is direly in need of reform, but innovating with noncompliant dosage forms and indications, without approved new drug applications, is a risk companies need to weigh seriously, says Arnall Golden Gregory partner Alan Minsk. The FDA offers perspective on its OTC monographs for acne and antiperspirant products.
National Advertising Division Shuts Down Skincarebrandsreviews Website
NourishMax agreed to discontinue “top pick” claims for its Diamond Infused Eye Cream and fold up its website that looked suspiciously to NAD like advertising in the guise of independent, honest reviews.
Cue The Class Actions! Plaintiffs React To Valisure’s Benzene Findings In Acne Drug Products
J&J, Target and Walgreens face class action complaints in California federal courts for economic harms caused by their sale of benzoyl peroxide-containing acne treatments, following Valisure’s 5 March citizen petition to the US FDA on findings of high levels of benzene in such products.